Page 13 of 23
The Journal of Organic Chemistry
δ 30.63. HRMS (CI-TOF) m/z calcd for C18H11BO2S2
([M]+) 334.0297, found 334.0287.
CDCl3): δ 30.33. 19F NMR (565 MHz, CDCl3): δ -62.58, -
62.61. HRMS (CI-TOF) m/z calcd for C24H1310BF6O2S
([M]+) 489.0670, found 489.0689.
1
2
3-(3-(benzo[d][1,3,2]dioxaborol-2-yl)benzo[b]thiophen-2-
yl)propyl acetate (2f). Prepared according to Procedure B
(4.0 h reaction time, 2.0 equiv ClBcat used). After the
reaction was complete, the solvent was removed in
vacuo, and the residue was redissolved in EtOAC (ca.
0.5 mL), and then loaded onto a C18 reversed-phase
column, and purified by column chromatography (100%
MeCN) to afford a white solid (0.053 g, 76% yield).
1H NMR (600 MHz, CDCl3): δ 8.56 (d, J = 8.0 Hz, 1H),
7.83 (d, J = 7.9 Hz, 1H), 7.47 (ddd, J = 8.2, 7.0, 1.1 Hz,
1H), 7.41–7.32 (m, 3H), 7.21–7.11 (m, 2H), 4.24 (t,
J = 6.4 Hz, 2H), 3.52–3.48 (t, J = 6.0 Hz, 2H), 2.25–2.15
(m, 2H), 2.08 (s, 3H). 13C NMR (151 MHz, CDCl3):
δ 171.2, 162.0, 147.9, 143.8, 139.3, 124.9, 124.8, 124.2,
123.0, 121.8, 112.7, 63.7, 31.2, 29.8, 27.7, 21.0. 11B NMR
(193 MHz, CDCl3): δ 30.31. HRMS (CI-TOF) m/z calcd for
C19H1710BO4SNH4 ([M+NH4]+) 369.1312, found 369.1312.
3
4
5
6
7
8
9
4-(benzo[d][1,3,2]dioxaborol-2-yl)-3-butyl-1H-
isochromen-1-one (2i). Prepared according to Procedure
B (24 h reaction time, 2.0 equiv ClBcat used). After the
reaction was complete, the solvent was removed in
vacuo, and the residue was redissolved in EtOAC (ca.
0.5 mL), and then loaded onto a C18 reversed-phase
column, and purified by column chromatography (100%
MeCN) to afford a white solid (0.043 g, 67% yield).
1H NMR (600 MHz, CDCl3): δ 8.38–8.24 (m, 2H), 7.75 (t,
J = 6.0 Hz, 1H), 7.49 (t, J = 7.6 Hz, 1H), 7.36 (dd, J = 5.9,
3.4 Hz, 2H), 7.18 (dd, J = 5.9, 3.3 Hz, 2H), 3.00 (t,
J = 6.0 Hz, 2H), 2.13–1.74 (m, 2H), 1.59–1.28 (m, 2H),
0.97 (t, J = 7.4 Hz, 3H). 13C{1H}NMR (151 MHz, CDCl3): δ
169.6, 162.3, 147.7, 138.8, 135.0, 129.6, 127.8, 126.5,
123.2, 119.9, 112.8, 34.1, 30.9, 22.5, 13.9. 11B NMR (193
MHz, CDCl3): δ 31.97. HRMS (CI-TOF) m/z calcd for
C19H17BO4 ([M]+) 320.1223, found 320.1233.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2-(2,5-diphenylthiophen-3-yl)benzo[d][1,3,2]dioxaborole
(2g). Prepared according to Procedure B (2.0 h reaction
time, 1.5 equiv ClBcat used). Two different purification
procedures were compared. In the first procedure, the
crude reaction mixture was directly loaded on a silica gel
column without removing the reaction solvent, and the
crude mixture was purified by silica gel column
chromatography (0–1% MeOH in DCM) to afford a white
solid (0.051 g, 72% yield). Alternatively, the crude product
could be purified by trituration, with the following
procedure: after reaction completion, the crude reaction
mixture was cooled to 25 ˚C, and pentane (HPLC grade)
was added dropwise (ca. 1 mL) to the crude reaction
mixture until a white precipitate was observed, then a few
more drops of pentane were added. This precipitate was
filtered via the frit in a Poly-Prep® Chromatography
Column and the residue was rinsed with pentane
(3 × 5 mL) and then redissolved in DCM (ca. 5 mL). The
resulting solution was concentrated in vacuo to afford the
product (0.047g, 67% yield). 1H NMR (600 MHz, CDCl3):
δ 7.89 (s, 1H), 7.80–7.65 (m, 4H), 7.55–7.40 (m, 5H), 7.34
(t, J = 7.5 Hz, 1H), 7.29–7.20 (m, 2H), 7.14–7.03 (m, 2H).
13C{1H}NMR (151 MHz, CDCl3): δ 156.4, 148.3, 144.4,
134.7, 133.9, 130.3, 129.5, 129.1, 128.7, 128.5, 127.9,
126.1, 122.9, 112.7. 11B NMR (193 MHz, CDCl3): δ 30.44.
HRMS (FI-TOF) m/z calcd for C22H15BO2S ([M]+)
354.0890, found 354.0896.
4-(benzo[d][1,3,2]dioxaborol-2-yl)-3-cyclopropyl-1H-
isochromen-1-one (2j). Prepared according to Procedure
B (24 h reaction time, 2.0 equiv ClBcat used). After the
reaction was complete, the solvent was removed in
vacuo, and the residue was redissolved in EtOAC
(ca. 0.5 mL), and then loaded onto a C18 reversed-phase
column, and purified by column chromatography (100%
MeCN) to afford a white solid (0.033 g, 55% yield).
1H NMR (600 MHz, CDCl3): δ 8.32 (d, J = 7.9 Hz, 1H),
8.26 (dd, J = 7.9, 1.5 Hz, 1H), 7.73 (dd, J = 8.5, 7.0 Hz,
1H), 7.43 (t, J = 7.6 Hz, 1H), 7.38–7.32 (m, 2H), 7.24–7.10
(m, 2H), 2.90 (tt, J = 8.0, 5.1 Hz, 1H), 1.42–1.31 (m, 2H),
1.14–1.02 (m, 2H). 13C{1H}NMR (151 MHz, CDCl3):
δ 169.0, 161.6, 147.8, 139.4, 135.1, 129.6, 127.2, 126.1,
123.2, 119.7, 112.7, 14.1, 9.3. 11B NMR (193 MHz,
CDCl3): δ 32.66. HRMS (CI-TOF) m/z calcd for C18H13BO4
([M]+) 304.0910, found 304.0913.
4-(benzo[d][1,3,2]dioxaborol-2-yl)-3-(3-chloropropyl)-1H-
isochromen-1-one (2k). Prepared according to Procedure
B (24 h reaction time, 2.0 equiv ClBcat used). After the
reaction was complete, the solvent was removed in
vacuo, and the residue was redissolved in EtOAC
(ca. 0.5 mL), and then loaded onto a C18 reversed-phase
column, and purified by column chromatography (100%
MeCN) to afford a white solid (0.047 g, 69% yield).
1H NMR (600 MHz, CDCl3): δ 8.33 (d, J = 9.2 Hz, 2H),
7.78 (td, J = 7.8, 1.5 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H),
7.41–7.33 (m, 2H), 7.23–7.15 (m, 2H), 3.66 (t, J = 6.3 Hz,
2H), 3.33–3.10 (m, 2H), 2.46–2.20 (m, 2H). 13C{1H}NMR
(151 MHz, CDCl3): δ 167.3, 162.0, 147.7, 138.5, 135.3,
129.7, 128.2, 126.7, 123.4, 120.0, 112.9, 44.3, 31.9, 31.1.
11B NMR (193 MHz, CDCl3): δ 32.07. HRMS (CI-TOF) m/z
calcd for C18H14BClO4 ([M]+) 340.0677, found 340.0690.
2-(2,5-bis(4-(trifluoromethyl)phenyl)thiophen-3-
yl)benzo[d][1,3,2]dioxaborole (2h). Prepared according to
Procedure B (5.0 h reaction time, 2.0 equiv ClBcat used).
After the reaction was complete, the solvent was removed
in vacuo, and the residue was redissolved in EtOAc (ca.
0.5 mL), and then loaded onto a C18 reversed-phase
column, and purified by column chromatography (100%
MeCN) to afford a dark green solid, and this solid was
further purified by recrystallizing from hot toluene (ca.
80 ˚C) to afford a white solid (0.065 g, 66% yield). 1H NMR
(600 MHz, CDCl3): δ 7.97 (s, 1H), 7.83 (d, J = 8.1 Hz, 2H),
7.78 (d, J = 8.1 Hz, 2H), 7.73 (d, J = 8.1 Hz, 2H), 7.68 (d,
J = 8.1 Hz, 2H), 7.31–7.23 (m, 2H), 7.17–7.10 (m, 2H).
13C{1H}NMR (151 MHz, CDCl3): δ 155.2, 148.1, 143.5,
137.8, 136.9, 132.0, 129.8, 126.2 (q, J = 4 Hz), 126.2,
125.5 (q, J = 4 Hz), 123.2, 112.8. 11B NMR (193 MHz,
General Experimental Procedure C: Synthesis of
Catechol Boronates 6a–6b. In a N2- or Ar-filled
glovebox, Cu(OTf)2 (0.0036 g, 0.010 mmol, 5.0 mol %)
and a stir bar was put into a one dram vial (“reaction vial”),
and this vial was kept in the glovebox for later use. ClBcat
(0.0308 g, 0.200 mmol, 1.0 equiv) was placed into a one
dram vial, followed by addition of 0.2 mL toluene to
dissolve the ClBcat. Then, the resulting solution was
transferred to a one dram vial (“substrate vial”) containing
ACS Paragon Plus Environment